Dolasetron


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 42.5%
Breast Cancer 15.0%
Colorectal Cancer Metastatic 10.0%
Prophylaxis Of Nausea And Vomiting 7.5%
Premedication 5.0%
Vomiting 5.0%
Anaesthesia 2.5%
Nausea 2.5%
Neuromuscular Blockade Reversal 2.5%
Oedema Peripheral 2.5%
Urinary Tract Infection 2.5%
Weight Decreased 2.5%
Vomiting 50.0%
Akathisia 16.7%
Electrocardiogram Qt Prolonged 16.7%
Ventricular Tachycardia 16.7%
Concomitant
Drug Use For Unknown Indication 22.2%
Nausea 11.7%
Pain 7.4%
Multiple Myeloma 6.2%
Non-small Cell Lung Cancer 6.2%
Premedication 5.3%
Colorectal Cancer Metastatic 5.1%
Neoplasm Malignant 3.9%
Prophylaxis Of Nausea And Vomiting 3.7%
Chronic Lymphocytic Leukaemia 3.5%
Anaesthesia 3.1%
Depression 3.1%
Gastrooesophageal Reflux Disease 2.7%
Prophylaxis 2.7%
Colon Cancer Stage Iii 2.3%
Constipation 2.3%
Hypertension 2.3%
Myelodysplastic Syndrome 2.1%
Colon Cancer 1.9%
Gastrooesophageal Cancer 1.9%
Vomiting 12.9%
Enterocutaneous Fistula 10.8%
Wheezing 9.7%
Headache 5.4%
Sepsis 5.4%
Total Lung Capacity Decreased 5.4%
Dehydration 4.3%
Infection 4.3%
Myocardial Infarction 4.3%
Oral Candidiasis 4.3%
Upper Gastrointestinal Haemorrhage 4.3%
Anaemia 3.2%
Deafness Neurosensory 3.2%
Left Ventricular Failure 3.2%
Liver Abscess 3.2%
Pleural Effusion 3.2%
Renal Failure Acute 3.2%
Stomatitis 3.2%
Tooth Disorder 3.2%
Tooth Extraction 3.2%

Drug Data